In many cardiology applications, companies developing vascular closure devices face an uphill battle. Vascular closure devices aid in sealing the puncture that’s made in the femoral artery to enable access to the vasculature. They’re adjunctive technologies that add costs to procedures, while competing with manual compression (pushing down on the wound by hand), a low cost, low-tech standard of care. In routine angioplasties and stent implantation procedures it is a matter of physician preference whether to use a closure device or to simply rely on compression. However, now that the femoral artery is being used to advance transcatheter aortic valves and other large devices for the treatment of structural heart disease, the demand for new tools for access site management changes from “nice-to-have” to “need-to-have.” (See Also see "As TAVI Advances, Adjunctive Devices Multiply" - Medtech Insight, 16 December, 2011..)
Avi Penner, PhD, founded Inseal Medical Ltd. in 2008 to develop a closure device designed to fill this new need. Penner explains that with respect to vascular access and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?